Clark Tingleaf, MD
Urology · Owasso, OKNPI 1881624153
Payments from drug & device makers
Across 26 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$90
- Calyxo, Inc.$30
- Avion Pharmaceuticals$30
- Boston Scientific$29
- Therapeuticsmd, Inc.$24
- Lupin Inc.$24
- plus $229 from 14 others
What the payments were for
- Food & beverage$44197%
- Education$153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 4 | $90 |
| Calyxo, Inc. | 1 | $30 |
| Avion Pharmaceuticals | 2 | $30 |
| Boston Scientific | 2 | $29 |
| Therapeuticsmd, Inc. | 2 | $24 |
| Lupin Inc. | 1 | $24 |
| Innovation Technologies Inc | 1 | $23 |
| Gilead | 1 | $21 |
| Roche Diagnostics Corporation | 1 | $21 |
| Civco Medical Instruments | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Davol Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Hollister Incorporated | 1 | $14 |
| Amgen | 1 | $13 |
| Laborie Medical Technologies Corp. | 1 | $13 |
| AbbVie | 1 | $13 |
How this compares
$456 in reported general payments places this provider in the 15th percentile of 145 urology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 28 | $22,624 |
| Potassium Citrate ErPotassium Citrate | 94 | $8,036 |
| Solifenacin Succinate | 84 | $5,130 |
| Tamsulosin Hcl | 363 | $3,244 |
| NitrofurantoinNitrofurantoin Macrocrystal | 100 | $2,060 |
| Oxybutynin Chloride | 27 | $817 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $583 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $306 |
| Finasteride | 52 | $229 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 46 | $213 |
| Ciprofloxacin Hcl | 23 | $210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $174 |
| Fluconazole | 12 | $167 |
| Cephalexin | 14 | $97 |
| Levofloxacin | 20 | $63 |
Paid to pharmacies, not to this prescriber.
Other urology in Owasso
- Kelly StrattonOklahoma City$1.9M
- Michael CooksonOklahoma City$658K
- Mohammad RamadanOklahoma City$215K
- Melanie KetchandjiTulsa$111K
- Curtis PowellTulsa$66K
- Basel HassounOklahoma City$46K
- Sanjay PatelOklahoma City$40K
- Ashley BowenOklahoma City$32K
- Marc MilstenTulsa$29K
- Scott LitwillerTulsa$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.